Related Experiment Video
Updated: Nov 4, 2025

Human Circadian Phenotyping and Diurnal Performance Testing in the Real World
Published on: April 7, 2020
Circadian, Week-to-Week, and Physical Exercise-Induced Variation of Serum Microfibrillar-Associated Protein 4
Susanne Gjørup Sækmose1,2, René Holst3, Tine Lottenburger4
1Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Abstract:
Serum microfibrillar-associated protein 4 (sMFAP4) has been investigated as a biomarker for various diseases and is demonstrated to show significant gradual increase with severity of liver fibrosis. Ideal biomarkers used for disease diagnosis or prognosis should display deviating levels in affected individuals only and be robust to factors unrelated to the disease. Here we show the impact of normal physiological variation of sMFAP4 by characterizing the circadian variation, week-to-week variation, and physical exercise-induced levels. Serum samples from 3 groups of healthy volunteers were drawn: 7 times during a 24-hour period, 5 times during a 3-week period, and before and after a standardized physical exercise challenge. sMFAP4 was determined by AlphaLISA. Statistical analysis was performed using mixed effects modeling of repeated measurements. Circadian variation of sMFAP4 was demonstrated, with time of peak and nadir values depending on age and gender. For males, the peak values were observed during nighttime whereas for females, peak values were observed in the morning. Individual sMFAP4 levels remained stable over a period of 3 weeks and physical exercise inferred a mild negative influence. In conclusion, the circadian sMFAP4 variation was significant, and the levels could be influenced by physical activity. However, these variations were of limited magnitude relative to previously observed disease-induced levels in support of the biomarker potential of sMFAP4.
Insights
Serum microfibrillar-associated protein 4 (sMFAP4) shows daily variations and is influenced by physical activity. These changes are minor, supporting sMFAP4
Area of Science:
- Biochemistry
- Clinical Chemistry
- Biomarker Discovery
Background:
- Serum microfibrillar-associated protein 4 (sMFAP4) is a potential biomarker for liver fibrosis.
- Biomarkers must be specific to disease states and unaffected by normal physiological variations.
- Understanding sMFAP4's normal variability is crucial for its clinical application.
Purpose of the Study:
- To investigate the impact of normal physiological variations on serum MFAP4 levels.
- To characterize circadian, week-to-week, and exercise-induced variations of sMFAP4.
Main Methods:
- Serum samples collected from healthy volunteers at multiple time points over 24 hours and 3 weeks.
- Samples analyzed before and after standardized physical exercise.
- sMFAP4 levels quantified using AlphaLISA and analyzed with mixed-effects modeling.
Main Results:
- Significant circadian variation in sMFAP4 levels was observed, with distinct patterns in males and females.
- sMFAP4 levels remained stable over a 3-week period.
- Physical exercise induced a mild negative influence on sMFAP4 levels.
Conclusions:
- Circadian rhythm and physical activity significantly influence sMFAP4 levels.
- These physiological variations are of limited magnitude compared to disease-induced changes.
- sMFAP4 retains its potential as a reliable biomarker for diseases like liver fibrosis.
Related Concept Videos
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
Circadian Rhythms and Gene Regulation

